BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

452 related articles for article (PubMed ID: 18308558)

  • 1. Immune surveillance: a balance between protumor and antitumor immunity.
    Ostrand-Rosenberg S
    Curr Opin Genet Dev; 2008 Feb; 18(1):11-8. PubMed ID: 18308558
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Role of T- and B-cell immunity in the pathogenesis of cancer].
    Savchenko AA; Borisov AG; Kudryavtsev IV; Moshev AV
    Vopr Onkol; 2015; 61(6):867-75. PubMed ID: 26995973
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Anti-tumor immunity: myeloid leukocytes control the immune landscape.
    Rutkowski MR; Stephen TL; Conejo-Garcia JR
    Cell Immunol; 2012; 278(1-2):21-6. PubMed ID: 23121972
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Roles of the immune system in cancer: from tumor initiation to metastatic progression.
    Gonzalez H; Hagerling C; Werb Z
    Genes Dev; 2018 Oct; 32(19-20):1267-1284. PubMed ID: 30275043
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Possible role of natural killer cells and other effector cells in immune surveillance against cancer.
    Herberman RB
    J Invest Dermatol; 1984 Jul; 83(1 Suppl):137s-140s. PubMed ID: 6376648
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tumor escape from immune response: mechanisms and targets of activity.
    Gabrilovich D; Pisarev V
    Curr Drug Targets; 2003 Oct; 4(7):525-36. PubMed ID: 14535653
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Innate immune mediators in cancer: between defense and resistance.
    Berraondo P; Minute L; Ajona D; Corrales L; Melero I; Pio R
    Immunol Rev; 2016 Nov; 274(1):290-306. PubMed ID: 27782320
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immunosurveillance and immunotherapy of tumors by innate immune cells.
    Iannello A; Thompson TW; Ardolino M; Marcus A; Raulet DH
    Curr Opin Immunol; 2016 Feb; 38():52-8. PubMed ID: 26686774
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Surveillance role of various leukocytes in preventing the outgrowth of potentially malignant cells.
    Urban J; Schreiber H
    Contemp Top Immunobiol; 1984; 13():225-42. PubMed ID: 6610532
    [No Abstract]   [Full Text] [Related]  

  • 10. T-cell-independent antitumor effects of CD40 ligation.
    Rakhmilevich AL; Alderson KL; Sondel PM
    Int Rev Immunol; 2012 Aug; 31(4):267-78. PubMed ID: 22804571
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The reversal immune surveillance hypothesis: part II.
    Daunter B; Mackay EV
    Med Hypotheses; 1981 May; 7(5):555-90. PubMed ID: 6456405
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Natural killer cells eradicate galectin-1-deficient glioma in the absence of adaptive immunity.
    Baker GJ; Chockley P; Yadav VN; Doherty R; Ritt M; Sivaramakrishnan S; Castro MG; Lowenstein PR
    Cancer Res; 2014 Sep; 74(18):5079-90. PubMed ID: 25038230
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Myeloid-derived suppressor cells: linking inflammation and cancer.
    Ostrand-Rosenberg S; Sinha P
    J Immunol; 2009 Apr; 182(8):4499-506. PubMed ID: 19342621
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Suppressor cells - the basis of the immunopathogenesis of cancer].
    Kozlov VA
    Vopr Onkol; 2016; 62(3):390-6. PubMed ID: 30462899
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Regulation of cellular immunity by activating transcription factor 4.
    Mukherjee D; Bercz LS; Torok MA; Mace TA
    Immunol Lett; 2020 Dec; 228():24-34. PubMed ID: 33002512
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Immune system and tumors].
    Terme M; Tanchot C
    Ann Pathol; 2017 Feb; 37(1):11-17. PubMed ID: 28159405
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The Yin-Yang of tumor-associated macrophages in neoplastic progression and immune surveillance.
    Allavena P; Sica A; Garlanda C; Mantovani A
    Immunol Rev; 2008 Apr; 222():155-61. PubMed ID: 18364000
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [The immune system - how does anti-tumor immunity arise ?].
    Sankawa Y
    Oncol Res Treat; 2014; 37 Suppl 4():2-5. PubMed ID: 25301189
    [No Abstract]   [Full Text] [Related]  

  • 19. The innate immune response to tumors and its role in the induction of T-cell immunity.
    Diefenbach A; Raulet DH
    Immunol Rev; 2002 Oct; 188():9-21. PubMed ID: 12445277
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Human tumor-infiltrating lymphocytes: a marker of host response.
    Vose BM; Moore M
    Semin Hematol; 1985 Jan; 22(1):27-40. PubMed ID: 3155876
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.